A novel biomarker with high sensitivity for hepatocellular carcinoma
Alexandra King
This article has no abstract so we have provided the first paragraph of the full text.
High mortality rates for hepatocellular carcinoma (HCC) and the increased prevalence of causative factors, such as chronic hepatitis and cirrhosis, have elicited a search for novel biomarkers with improved specificity and sensitivity in the early detection of HCC. Beneduce et al. have recently developed ELISA assays to compare the diagnostic accuracy of squamous cell carcinoma antigen (SCCA) variants, identified as being overexpressed in the livers of patients with HCC, with 
-fetoprotein (AFP), currently the biomarker most widely used in the detection of HCC.
Full text of this article is available with one of the following:
- Membership of the American College of Gastroenterology. If already a member, please login.
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Mal-function of TLRs by SOCSNature Immunology News and Views (01 Feb 2006)
Solar size variationNature News and Views (31 Jul 1980)
